Citations

Clear

696 citation(s) found for "Tyler, A".

Applications of a New Handheld Reference Point Indentation Instrument Measuring Bone Material Strength
Randall, Connor, Bridges, Daniel , Nogués, Xavier , Torres, Elisa, Mellibovsky, Leonardo , Hoffseth, Kevin , Stalbaum, Tyler, Srikanth, Ananya, Weaver, James C. , Rosen, Sasha, Barnard, H. R. , Brimer, Davis, Proctor, Alex, Candy, James V., Saldaña, Christopher , Chandrasekar, Srinivasan , Lescun, Timothy B. , Nielson, Carrie M. , Herthel, D. J., Kopeikin, Hal, Yang, Henry T. Y., McCready, Louise K., Khosla, Sundeep , Hansma, Paul K. , Güerri‐Fernández, Robert , Puig, Lluís , Orwoll, Eric , Farr, Joshua N. , Díez‐Pérez, Adolfo , Khosla, Sundeep

Mayo Clinic

Journal of Medical Devices | September 24, 2013 | Volume: 7 | Issue: 4 | Pages: No page available

10.1115/1.4024829 | PMID 24115973 Get It

A novel, hand-held Reference Point Indentation (RPI) instrument, measures how well the bone of living patients and large animals resists indentation. The results presented here are reported in terms of Bone Material Strength, which is a normalized measure of how well the bone resists indentation, and is inversely related to the indentation distance into the bone. We present examples of the instrument's use in: (1) laboratory experiments on bone, including experiments through a layer of soft tissue, (2) three human clinical trials, two ongoing in Barcelona and at the Mayo Clinic, and one completed in Portland, OR, and (3) two ongoing horse clinical trials, one at Purdue University and another at Alamo Pintado Stables in California. The instrument is capable of measuring consistent values when testing through soft tissue such as skin and periosteum, and does so handheld, an improvement over previous Reference Point Indentation instruments. Measurements conducted on horses showed reproducible results when testing the horse through tissue or on bare bone. In the human clinical trials, reasonable and consistent values were obtained, suggesting the Osteoprobe® is capable of measuring Bone Material Strength in vivo, but larger studies are needed to determine the efficacy of the instrument's use in medical diagnosis.
Lipoid Granulomata in Scalene Node
Warner, Tyler

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 84 | Issue: 6 | Pages: 755-755

10.7326/0003-4819-84-6-755_1 | PMID 937901 Get It

Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease
Egan, Jan B. , Kortuem, K. Martin, Kurdoglu, Ahmet, Izatt, Tyler, Aldrich, Jessica, Reiman, Rebecca, Baker, Angela , Shi, Chang‐Xin, Schmidt, Jessica, Liang, Winnie S. , Craig, David W. , Carpten, John D. , Stewart, A. Keith, Phillips, L Taylor

Mayo Clinic

British Journal of Haematology | March 13, 2013 | Volume: 161 | Issue: 5 | Pages: 748-751

10.1111/bjh.12291 | PMID 23480694 Get It

Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson's Disease Cases Lacking Alzheimer's Disease Pathology
Maarouf, Chera L., Beach, Thomas G., Malek‐Ahmadi, Michael , Kokjohn, Tyler A., Dugger, Brittany N. , Walker, Douglas G. , Shill, Holly A. , Jacobson, Sandra A. , Roher, Alex E., Adler, Charles H. , Sabbagh, Marwan Noel , Dugger, Brittany N

Mayo Clinic

Biomarker Insights | March 12, 2013 | Volume: 8 | Issue: No issue available | Pages: BMI.S11422

10.4137/bmi.s11422 | PMID 23533154 Get It

Identifying biomarkers that distinguish Parkinson's disease (PD) from normal control (NC) individuals has the potential to increase diagnostic sensitivity for the detection of early-stage PD. A previous proteomic study identified potential biomarkers in postmortem ventricular cerebrospinal fluid (V-CSF) from neuropathologically diagnosed PD subjects lacking Alzheimer's disease (AD) neuropathology. In the present study, we assessed these biomarkers as well as p-tau 181 , Aβ42, and S100B by ELISA in PD (n = 43) and NC (n = 49) cases. The p-tau 181 /Aβ42 ratio and ApoA-1 showed statistically significant differences between groups. Multiple regression analysis demonstrated that p-tau 181 /Aβ42 had a significant odds ratio: OR = 1.42 (95% confidence interval [CI], 1.12–1.84), P = 0.006. Among the molecules investigated, intriguing correlations were observed that require further investigation. Our results suggest coexistent AD CSF biomarkers within the PD group notwithstanding that it was selected to minimize AD neuropathological lesions.
Perceptions and Practices of Therapeutic Hypothermia in American Neonatal Intensive Care Units
Harris, Malinda N. , Ellsworth, Marc A., Haas, Lindsey R., Hartman, Tyler, Lang, Tara R., Colby, Christopher E. , Carey, William A.

Mayo Clinic

American Journal of Perinatology | March 2, 2013 | Volume: 31 | Issue: 01 | Pages: 015-020

10.1055/s-0033-1334454 | PMID 23456901 Get It

Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
Maarouf, Chera L., Beach, Thomas G. , Shill, Holly A. , Wu, Terence , Walker, Douglas G, Kokjohn, Tyler A., Roher, Alex E., Consortium, Arizona PD, Adler, Charles H. , Sabbagh, Marwan Noel , Walker, Douglas G

Mayo Clinic

Neurological Research | August 14, 2012 | Volume: 34 | Issue: 7 | Pages: 669-676

10.1179/1743132812y.0000000063 | PMID 22889670 Get It